These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 23169946

  • 1. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials.
    Perez MV, Wang PJ, Larson JC, Virnig BA, Cochrane B, Curb JD, Klein L, Manson JE, Martin LW, Robinson J, Wassertheil-Smoller S, Stefanick ML.
    Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946
    [Abstract] [Full Text] [Related]

  • 2. Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.
    Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH, Women's Health Initiative Memory Study.
    JAMA; 2004 Jun 23; 291(24):2947-58. PubMed ID: 15213206
    [Abstract] [Full Text] [Related]

  • 3. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A, Martin CF, Peck JD, Aragaki AK, Chlebowski RT, Pisano ED, Wang CY, Brunner RL, Johnson KC, Manson JE, Lewis CE, Kotchen JM, Hulka BS, Women's Health Initiative Mammogram Density Study Investigators.
    J Natl Cancer Inst; 2005 Sep 21; 97(18):1366-76. PubMed ID: 16174858
    [Abstract] [Full Text] [Related]

  • 4. Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial.
    Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J, Women's Health Initiative Investigators.
    Am J Epidemiol; 2005 Sep 01; 162(5):404-14. PubMed ID: 16033876
    [Abstract] [Full Text] [Related]

  • 5. Venous thrombosis and conjugated equine estrogen in women without a uterus.
    Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Cyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR.
    Arch Intern Med; 2006 Apr 10; 166(7):772-80. PubMed ID: 16606815
    [Abstract] [Full Text] [Related]

  • 6. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.
    Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Women's Health Initiative Steering Committee.
    JAMA; 2004 Apr 14; 291(14):1701-12. PubMed ID: 15082697
    [Abstract] [Full Text] [Related]

  • 7. Menopausal hormone therapy and risks of melanoma and nonmelanoma skin cancers: women's health initiative randomized trials.
    Tang JY, Spaunhurst KM, Chlebowski RT, Wactawski-Wende J, Keiser E, Thomas F, Anderson ML, Zeitouni NC, Larson JC, Stefanick ML.
    J Natl Cancer Inst; 2011 Oct 05; 103(19):1469-75. PubMed ID: 21878677
    [Abstract] [Full Text] [Related]

  • 8. Estrogen plus progestin and the risk of peripheral arterial disease: the Women's Health Initiative.
    Hsia J, Criqui MH, Rodabough RJ, Langer RD, Resnick HE, Phillips LS, Allison M, Bonds DE, Masaki K, Caralis P, Kotchen JM, Women's Health Initiative Investigators.
    Circulation; 2004 Feb 10; 109(5):620-6. PubMed ID: 14769684
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular risk in women with non-specific chest pain (from the Women's Health Initiative Hormone Trials).
    Robinson JG, Wallace R, Limacher M, Ren H, Cochrane B, Wassertheil-Smoller S, Ockene JK, Blanchette PL, Ko MG.
    Am J Cardiol; 2008 Sep 15; 102(6):693-9. PubMed ID: 18773990
    [Abstract] [Full Text] [Related]

  • 10. Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.
    Maturitas; 2006 Sep 20; 55(2):103-15. PubMed ID: 16815651
    [Abstract] [Full Text] [Related]

  • 11. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM, Cochrane BB, Aragaki AK, Nygaard I, Williams RS, McGovern PG, Young RL, Wells EC, O'Sullivan MJ, Chen B, Schenken R, Johnson SR, Women's Health Initiative Investigators.
    Obstet Gynecol; 2005 May 20; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [Abstract] [Full Text] [Related]

  • 12. Estrogen plus progestin and the risk of coronary heart disease.
    Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators.
    N Engl J Med; 2003 Aug 07; 349(6):523-34. PubMed ID: 12904517
    [Abstract] [Full Text] [Related]

  • 13. Estrogen plus progestin and colorectal cancer in postmenopausal women.
    Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, Hubbell FA, Ascensao J, Rodabough RJ, Rosenberg CA, Taylor VM, Harris R, Chen C, Adams-Campbell LL, White E, Women's Health Initiative Investigators.
    N Engl J Med; 2004 Mar 04; 350(10):991-1004. PubMed ID: 14999111
    [Abstract] [Full Text] [Related]

  • 14. Postmenopausal hormone use and the risk of nephrolithiasis: results from the Women's Health Initiative hormone therapy trials.
    Maalouf NM, Sato AH, Welch BJ, Howard BV, Cochrane BB, Sakhaee K, Robbins JA.
    Arch Intern Med; 2010 Oct 11; 170(18):1678-85. PubMed ID: 20937929
    [Abstract] [Full Text] [Related]

  • 15. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.
    Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R, Women's Health Initiative Investigators.
    Arch Intern Med; 2006 Feb 13; 166(3):357-65. PubMed ID: 16476878
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of estrogen plus progestin on menopausal symptoms in women with systemic lupus erythematosus: a randomized, double-blind, controlled trial.
    Cravioto MD, Durand-Carbajal M, Jiménez-Santana L, Lara-Reyes P, Seuc AH, Sánchez-Guerrero J.
    Arthritis Care Res (Hoboken); 2011 Dec 13; 63(12):1654-63. PubMed ID: 22127965
    [Abstract] [Full Text] [Related]

  • 17. A comparative review of the risks and benefits of hormone replacement therapy regimens.
    Warren MP.
    Am J Obstet Gynecol; 2004 Apr 13; 190(4):1141-67. PubMed ID: 15118656
    [Abstract] [Full Text] [Related]

  • 18. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr 13; 12(64):65-9. PubMed ID: 12674130
    [Abstract] [Full Text] [Related]

  • 19. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF, Oger E.
    Climacteric; 2012 Jun 13; 15(3):235-40. PubMed ID: 22612609
    [Abstract] [Full Text] [Related]

  • 20. New evidence regarding hormone replacement therapies is urgently required transdermal postmenopausal hormone therapy differs from oral hormone therapy in risks and benefits.
    Modena MG, Sismondi P, Mueck AO, Kuttenn F, Lignières Bd, Verhaeghe J, Foidart JM, Caufriez A, Genazzani AR, TREAT.
    Maturitas; 2005 Sep 16; 52(1):1-10. PubMed ID: 15963666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.